M Evo Global Acquisition Corp II (MEVO) Company Overview

US | Financial Services | Financial - Conglomerates | NASDAQ

What does M Evo Global Acquisition Corp II do?

M Evo Global Acquisition Corp II is a Cayman Islands special purpose acquisition company, or SPAC, whose Class A ordinary shares trade on Nasdaq under the ticker MEVO. It has no operating business, customers, products, or revenue-generating subsidiaries. Its purpose is to identify a private company, negotiate a transaction, obtain shareholder and regulatory approvals, and combine with that target so the resulting enterprise becomes publicly traded. The company’s quarterly report for March 31, 2026 confirms that it had not commenced operations and would not generate operating revenue before a business combination.

MEVO
Nasdaq Class A ordinary share ticker
$300.0M
IPO gross proceeds, February 2, 2026
30.0M
Public shares issued in the IPO
24 months
Initial completion window from IPO closing

Why is this company different from an operating business?

A conventional company is analyzed through sales, market share, unit economics, margins, and competitive positioning. MEVO must instead be analyzed through trust-account value, redemption rights, sponsor incentives, warrant dilution, deal-selection quality, completion risk, and the economics of any future target. Until a transaction closes, the principal asset is cash and investments held in trust, while the principal strategic activity is searching for a suitable acquisition.

What is the intended target universe?

The charter does not legally restrict MEVO to one industry or geography, but the final IPO prospectus describes a preference for businesses connected to critical minerals, natural resources, processing, refining, recycling, and supply chains important to United States economic and national security. That focus gives the search a sector thesis, yet it does not guarantee that the eventual target will be profitable, mature, or located in the United States.

How does MEVO create value, and where could returns come from?

MEVO does not currently make money from selling goods or services. Before a combination, its recurring income is primarily interest earned on the trust account. The economic proposition is that management will find a private company whose public-market value, growth prospects, strategic assets, or financing needs justify a merger. Public shareholders then choose whether to remain invested in the combined company or redeem their shares for their pro rata portion of the trust.

Step 1
Raise capital
The IPO sold 30.0 million units at $10.00 each.
Step 2
Protect funds
Most proceeds were placed in a trust account invested in permitted assets.
Step 3
Source a target
Management evaluates private businesses and negotiates transaction terms.
Step 4
Vote or redeem
Public holders can assess the proposed deal and exercise redemption rights.
Step 5
Combine or liquidate
A completed deal creates an operating public company; failure leads toward redemption and wind-down.

What securities did investors receive?

Each IPO unit was sold for $10.00 and contained one Class A ordinary share plus one-half of one redeemable warrant. Two half-warrants are therefore required to form one whole public warrant, and each whole warrant may ultimately purchase one Class A share at an exercise price of $11.50, subject to the warrant terms. The securities were registered for Nasdaq trading through the company’s Form 8-A registration and began separate trading in February 2026: units under MEVOU, Class A shares under MEVO, and warrants under MEVOW, as described in the company’s separate-trading Form 8-K.

Security Terms at issuance Investor relevance
Unit (MEVOU) $10.00; one Class A share plus one-half warrant Bundled exposure before or without separation.
Class A share (MEVO) One public share with redemption rights Primary trust-backed instrument before the merger vote.
Public warrant (MEVOW) $11.50 exercise price per whole warrant Leveraged upside if a transaction closes and the post-deal share price performs.
Founder shares 10.0 million Class B shares outstanding at March 31, 2026 Sponsor economics and potential post-combination dilution.

What does the latest reported period show?

The quarter ended March 31, 2026 is MEVO’s first meaningful public-company reporting period after the IPO. The balance sheet is dominated by the trust account, not operating assets. Total assets were $302.9 million, including $301.7 million of investments held in trust and $1.0 million of cash and cash equivalents outside the trust. The trust represented approximately 99.6% of total assets, illustrating that the investment case is still primarily a capital-allocation and transaction-selection case.

$301.7M
Investments held in trust, March 31, 2026
$10.06
Redemption value per public share, March 31, 2026
$1.7M
Trust interest income, Q1 2026
$(7.0M)
Net loss, Q1 2026

Why did MEVO report a large accounting loss?

For Q1 2026, MEVO recorded $189,221 of general and administrative costs, $8.47 million of compensation expense, and $1.67 million of interest income, producing a $6.99 million net loss. The compensation expense largely reflected the fair value assigned to founder-share interests granted to officers and directors rather than a cash drain of the same size. Operating cash use was only $135,394 for the quarter. This difference matters: the income statement showed a substantial loss, but the near-term liquidity signal was much less severe.

Q1 2026 income-statement drivers
Compensation expense$8.47M
Trust interest income$1.67M
G&A costs$0.19M
The non-cash founder-share compensation charge dominated the quarter; bars are scaled to the largest absolute item.
Metric Q1 2026 / March 31, 2026 Interpretation
Total assets $302.92M Nearly all assets were trust investments.
Total liabilities $12.13M Included a $12.00M deferred underwriting fee payable upon a successful deal.
Cash outside trust $1.04M Funds search, diligence, legal, listing, and administrative costs.
Operating cash used $0.14M More relevant to runway than the non-cash-heavy net loss.
Public shares subject to redemption 30.0M at $10.06 Redemption value totaled $301.67M.

How should the trust account and capital structure be interpreted?

The trust account is the core protective mechanism for public shareholders before a business combination. At March 31, 2026, the trust held $301.67 million against 30.0 million redeemable shares, equal to $10.06 per share. Its growth above the $10.00 IPO price came from interest earned after closing. However, the trust is not the same as unrestricted corporate cash: it is generally reserved for redemptions, transaction completion, taxes, and permitted withdrawals under the governing documents.

99.6%of total assets at March 31, 2026 consisted of investments held in the trust account.

What is the difference between trust value and working capital?

MEVO had about $1.04 million of cash and cash equivalents outside the trust at quarter-end. This outside cash is the practical budget for target screening, professional fees, negotiations, due diligence, shareholder materials, and public-company administration. Management stated in the quarterly filing that it believed existing funds were sufficient for working-capital needs for at least one year from issuance of the financial statements, although actual transaction costs could exceed estimates.

Protected transaction pool
$301.67M
Trust investments at March 31, 2026; principally supports redemptions or a completed deal.
Operating liquidity
$1.04M
Cash and cash equivalents outside trust at March 31, 2026.

Where does dilution enter the structure?

Dilution can arise from 10.0 million founder shares, 15.0 million public warrants embedded in the IPO units, 8.0 million private placement warrants, transaction financing, target-owner rollover equity, and any later working-capital warrants. The private placement included 5.0 million warrants purchased by the sponsor and 3.0 million purchased by the underwriters at $1.00 each. These instruments are not equivalent to trust-backed public shares and may become economically important after a merger.

Potential warrant pool by source
Public warrants — 15.0M, or 65.2% of the 23.0M identified warrant pool
Sponsor private warrants — 5.0M, or 21.7%
Underwriter private warrants — 3.0M, or 13.1%
Potential dilution depends on deal completion, exercisability, share price, redemptions, and the final transaction structure.

What strategic history explains MEVO’s current setup?

MEVO’s history is short, but each formation and financing step materially shaped its present economics. Unlike a mature company timeline, the relevant milestones are incorporation, capitalization, IPO approval, trust funding, listing, and the beginning of the acquisition search.

  1. August 11, 2025
    The company was incorporated in the Cayman Islands as Evolution Global Acquisition Corp II, establishing the blank-check vehicle.
  2. August 26, 2025
    The company changed its name to M Evo Global Acquisition Corp II, aligning the vehicle with the sponsor group’s identity.
  3. August 2025
    The sponsor funded formation costs in exchange for founder shares, creating the promote and the sponsor’s central economic incentive.
  4. January 29, 2026
    The SEC declared the IPO registration statement effective; founder-share capitalization was adjusted to 10.0 million shares.
  5. February 2, 2026
    MEVO closed a 30.0 million-unit IPO at $10.00 per unit, raising $300.0 million gross and fully exercising the over-allotment option.
  6. February 19, 2026
    Class A shares and warrants became eligible for separate trading, giving investors distinct trust-backed and option-like instruments.
  7. March 31, 2026
    The first quarter-end balance sheet showed $301.67 million in trust investments and no announced operating target.

Why does the critical-minerals orientation matter?

The prospectus frames critical minerals as a market shaped by energy transition, defense requirements, geopolitical concentration, processing bottlenecks, and government support. A target in this field could offer strategically important assets and policy-backed demand, but it may also bring permitting risk, commodity-price volatility, technical complexity, high capital requirements, environmental obligations, and long development timelines. Thus, the sector thesis is not automatically a moat; target quality and transaction price remain decisive.

For MEVO, the strategic question is not whether critical minerals are important; it is whether the sponsor can acquire a financeable asset at a valuation that survives public-market scrutiny and redemptions.

Who controls MEVO, and why do sponsor incentives matter?

Evolution Sponsor Holdings LLC II is the sponsor and held 10.0 million Class B founder shares at March 31, 2026. With 30.0 million public shares outstanding, the founder shares represented 25% of the issued shares on an as-converted pre-combination basis, before considering warrants. The sponsor’s managing members are Stephen Silver, Chief Executive Officer and board chair; Ashley Zumwalt-Forbes, Chief Operating Officer and director; and John Charles Forbes II. The sponsor’s control over the founder shares makes it the dominant pre-combination insider.

Holder or group Economic position Source period Why it matters
Evolution Sponsor Holdings LLC II 10.0M founder shares March 31, 2026 Controls the sponsor promote and has strong incentive to complete a deal.
Sponsor 5.0M private placement warrants IPO closing Adds post-deal upside but no redemption protection.
Underwriters 3.0M private placement warrants IPO closing Creates additional potential dilution and transaction-linked economics.
Officers and directors Interests equivalent to 3.44M founder shares were granted January 29, 2026 Aligns management with completion but can increase urgency to transact.

How should the promote be interpreted?

Founder shares were originally acquired for nominal consideration relative to the public IPO price. They can become valuable if a transaction closes, while generally becoming worthless if the SPAC liquidates. This asymmetry creates both motivation and conflict: management is rewarded for finding a deal, but the private economics may favor completion even when public shareholders are skeptical. The company’s filings explicitly discuss this incentive risk and the potential for sponsor interests to differ from those of public holders.

What governance conflict deserves attention?

Several MEVO officers and directors also serve another blank-check company, Evolution Global Acquisition Corp. The prospectus says that entity generally has priority over MEVO for acquisition opportunities until it completes a business combination, enters restrictions, or ceases operations. There is no contractual allocation agreement governing which vehicle receives a particular opportunity. Researchers should therefore assess whether overlapping duties could constrain sourcing, timing, or target access.

What gives MEVO an advantage in the SPAC market?

MEVO’s potential advantage is not an operating moat. It is a combination of capital scale, sponsor networks, sector knowledge, transaction experience, and access to technical or policy relationships. A $300.0 million IPO provides a meaningful equity pool for a target, while redemptions, additional financing, and transaction terms determine how much cash ultimately reaches the combined business.

Trust-account scaleStrong
Sector specializationFocused
Operating track recordNot applicable
Current revenue visibilityNone

Who are the real competitors?

MEVO competes with other SPACs, private-equity funds, strategic acquirers, infrastructure investors, mining companies, sovereign investors, and conventional IPO advisers for attractive targets. In critical minerals, competition can be especially intense for projects with advanced permitting, credible resource estimates, experienced operators, government support, and near-term production potential. Sellers can compare transaction certainty, valuation, sponsor reputation, available cash, earn-outs, board composition, and post-closing financing support.

High specialization / meaningful capital
MEVO’s intended position: a large trust account paired with a critical-minerals-focused sponsor thesis.
Low specialization / meaningful capital
Generalist SPACs can offer scale but may lack sector-specific diligence or operating networks.
High specialization / limited capital
Specialist funds may understand assets well but require syndication or project-level financing.
Low specialization / limited capital
Smaller generalists may struggle to compete for advanced, capital-intensive targets.

The matrix is an analytical positioning tool, not an official market-share claim. MEVO has not yet demonstrated an ability to close a transaction, integrate a business, or create public-company value. Its proposed advantage remains prospective until a target is announced and the transaction terms can be evaluated.

Which risks could change MEVO’s outlook?

The most important risk is binary: MEVO may fail to complete a suitable combination within its completion window. The prospectus provides an initial 24-month period from the February 2, 2026 IPO closing, subject to the governing documents and any shareholder-approved extension. If no deal is completed, public shares are generally redeemed from the trust, while warrants can expire worthless and sponsor securities may lose their value.

Risk Financial mechanism What to monitor
No transaction Liquidation eliminates the operating-company upside and can make warrants worthless. Target announcement, shareholder deadlines, extension proposals.
High redemptions Less trust cash reaches the target, increasing reliance on PIPE or debt financing. Redemption percentage and minimum-cash conditions.
Overpayment A rich valuation can transfer value to sellers and pressure the post-deal share price. Enterprise value, peer multiples, earn-outs, sponsor concessions.
Dilution Founder shares, warrants, financing shares, and rollover equity enlarge the share count. Fully diluted capitalization and warrant treatment.
Critical-minerals execution Permitting, capex, commodity prices, and technical setbacks can delay cash flow. Feasibility studies, permits, funding, offtake, construction milestones.
Conflicts of interest Overlapping duties may affect opportunity allocation and transaction incentives. Related-party disclosures, fairness process, board review.

What macro risks are specifically disclosed?

The Q1 filing identifies changes in laws and regulations, market downturns, inflation, interest-rate fluctuations, tariffs, supply-chain disruption, reduced consumer confidence, public-health events, and geopolitical instability as factors that could impair the ability to complete a business combination. These risks matter because they affect target valuations, financing availability, commodity economics, and investor willingness to support a merger.

Which KPIs matter most before and after a deal?

Traditional operating KPIs do not yet apply because MEVO has no revenue or business segment. Researchers should instead track transaction-process metrics. The most informative indicators are trust value per share, cash outside trust, operating cash burn, time remaining, redemption levels, financing commitments, fully diluted share count, and the quality of any announced target’s disclosures.

Trust value per share
$10.06 at March 31, 2026; indicates the redemption base before taxes, withdrawals, and later interest.
Outside-trust liquidity
$1.04M at March 31, 2026; funds search and transaction expenses.
Quarterly cash burn
$0.14M operating cash used in Q1 2026; compare with remaining liquidity.
Redemption rate
Not yet applicable; becomes central when shareholders vote on a transaction.
Minimum cash
Not yet disclosed; a future merger agreement may require a minimum closing cash balance.
Fully diluted shares
Must include founder shares, public and private warrants, seller shares, and financing securities.
Target capex needs
Especially important for mining, processing, recycling, and infrastructure assets.
Completion timetable
The initial 24-month deadline makes elapsed time a strategic and financial variable.

How does the KPI set change after a target announcement?

Once MEVO identifies a target, the analysis should pivot to the target’s resource quality, permits, production schedule, customer contracts, revenue, EBITDA, free cash flow, capital spending, debt, ownership rollover, and valuation. For a development-stage critical-minerals company, researchers may need to emphasize reserves or resources, recovery rates, feasibility assumptions, construction cost, offtake commitments, funding gaps, and commodity-price sensitivity rather than near-term earnings.

Stage Primary metrics Core question
Pre-announcement Trust value, liquidity, cash burn, time remaining Can MEVO preserve optionality while sourcing a credible target?
Signed transaction Valuation, redemptions, PIPE, minimum cash, dilution Does the capital structure leave enough value and funding for public holders?
Post-combination Revenue, margins, capex, cash flow, leverage, milestones Can the operating company execute the plan used to justify the merger?

Why does MEVO’s structure matter for valuation?

A normal discounted cash flow model cannot be built for MEVO today because there are no operating revenues, margins, or business cash flows to forecast. Before a target is announced, valuation is better framed as trust value plus transaction optionality, adjusted for time, taxes, expected expenses, deal probability, redemption mechanics, and the separate value of warrants. The common share’s downside characteristics can differ materially from the warrant’s because the share has redemption rights while the warrant does not.

Public-share valuation anchor
$10.06 trust value
Per redeemable share at March 31, 2026, before future changes and transaction effects.
Warrant valuation anchor
$11.50 strike
Exercise price per whole warrant, subject to terms and adjustments.

What should a post-announcement valuation include?

After a merger is proposed, analysts should separate enterprise value from equity value, calculate the cash actually delivered after redemptions and fees, and build a fully diluted share count. The $12.0 million deferred underwriting fee recorded at March 31, 2026 is one transaction-linked cost. Other potential claims include sponsor shares, warrants, seller rollover equity, new financing securities, advisory fees, and earn-outs. A target’s headline enterprise value can therefore differ substantially from the effective value accruing to each public share.

Valuation driver Why it matters Evidence needed
Redemptions Reduce cash delivered and can increase financing dependence. Vote results and closing statement.
Sponsor dilution Changes ownership per public share and may be renegotiated. Merger agreement and sponsor support agreement.
Warrant overhang Potential future issuance affects fully diluted equity value. Warrant agreement and pro forma capitalization.
Target free cash flow Supports a conventional DCF only when operating forecasts are credible. Audited financials, projections, capex, working capital.
Commodity and project risk Raises discount rates and may delay terminal cash generation. Technical reports, permits, contracts, sensitivity analysis.

What should students and investors monitor next?

The next phase of the MEVO story will be determined by transaction sourcing rather than quarterly revenue growth. The company’s most recent filing available through the first quarter of 2026 showed a well-funded trust and modest cash burn outside the trust, but no operating target. The announcement of a target would immediately make transaction valuation, capital needs, governance, and target-specific execution more important than the current balance sheet.

Target announcement
Identity, jurisdiction, asset maturity, and strategic rationale.
Transaction valuation
Enterprise value, equity value, peer basis, and seller rollover.
Funding package
Trust cash, PIPE, debt, grants, offtake finance, and minimum cash.
Redemptions
The percentage of public shares redeemed at the transaction vote.
Sponsor concessions
Forfeitures, vesting, earn-outs, or warrant changes that affect dilution.
Target milestones
Permits, feasibility, construction, commissioning, production, and customer contracts.
Liquidity runway
Outside-trust cash and any working-capital loans while negotiations continue.
Completion deadline
Any extension request, shareholder vote, or change to the liquidation timetable.

The official IPO closing announcement established the $300.0 million starting pool, while the February 2, 2026 audited balance sheet and the latest quarterly filing provide the baseline for tracking trust growth, liabilities, and liquidity.

Final analytical takeaway
MEVO is not yet a critical-minerals operating company; it is a transaction vehicle with a $301.7 million trust account, a sponsor-led acquisition mandate, and a finite timetable. Its strengths are capital scale, a defined sector orientation, and redemption protection for public shares before a deal. Its weaknesses are the absence of operating cash flow, sponsor dilution, conflicts around deal incentives, and dependence on finding a target that can withstand financing, regulatory, commodity, and execution risk. The decisive evidence will arrive only when management presents a specific transaction and a fully diluted capital structure.

DCF model

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support



Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.

(MEVO) M Evo Global Acquisition Corp II Bundle

Get Full Bundle:
$17 $9
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5